$TEVA SEC Filings

Filing Filed On
TEVA INVITES PUBLIC TO LISTEN TO INVESTOR DAY WEBCAST 19 Feb 2008
SC 13G/A 14 Feb 2008
TEVA PROVIDES 2008 AND 2009 FINANCIAL OUTLOOK 12 Feb 2008
TEVA REPORTS FOURTH QUARTER AND FULL YEAR 2007 RESULTS 12 Feb 2008
TEVA PHARMACEUTICALS INDUSTRIES LIMITED 08 Feb 2008
TEVA ANNOUNCES APPROVAL OF GENERIC FOSAMAX? TABLETS 5 MG, 10 MG, 35 MG, 40 MG AN 07 Feb 2008
TEVA PROVIDES UPDATE ON GENERIC PROTONIX? 04 Feb 2008
TEVA ANNOUNCES TENTATIVE APPROVAL OF GENERIC FLOMAX? CAPSULES 31 Jan 2008
TEVA ANNOUNCES WYETH VOIDS STANDSTILL AGREEMENT ON GENERIC PROTONIX? 30 Jan 2008
TEVA TO PRESENT AT THE 2008 WACHOVIA HEALTHCARE CONFERENCE 29 Jan 2008
TEVA TO REPORT FOURTH QUARTER AND FULL YEAR 2007 FINANCIAL RESULTS ON FEBRUARY 1 29 Jan 2008
TEVA ANNOUNCES TENTATIVE APPROVAL OF GENERIC PREVACID? DELAYED-RELEASE CAPSULES 29 Jan 2008
TEVA TO ACQUIRE COGENESYS ACQUISITION WILL BOLSTER TEVA???S BIOTECHNOLOGY CAPABI 22 Jan 2008
TEVA ANNOUNCES EXTENSION TO STANDSTILL AGREEMENT ON GENERIC PROTONIX? 22 Jan 2008
TEVA ANNOUNCES APPROVAL OF PRAVASTATIN SODIUM TABLETS, 80 MG 22 Jan 2008
TEVA SPECIALTY PHARMACEUTICALS AND UCB ANNOUNCE U.S. RESPIRATORY COLLABORATION A 17 Jan 2008
TEVA ANNOUNCES TENTATIVE APPROVAL OF GENERIC ARICEPT? TABLETS 15 Jan 2008
TEVA TO EXPLORE STRATEGIC ALTERNATIVES FOR ITS ANIMAL HEALTH BUSINESS 14 Jan 2008
TEVA ANNOUNCES DEPARTURE OF NORTH AMERICAN CEO WILLIAM S. MARTH TO BECOME CEO OF 10 Jan 2008
TEVA TO PRESENT AT THE MORGAN STANLEY PHARMACEUTICAL CEO'S UNPLUGGED CONFERENCE 03 Jan 2008